Published in BJU Int on April 01, 2006
The alpha-1D Is the predominant alpha-1-adrenergic receptor subtype in human epicardial coronary arteries. J Am Coll Cardiol (2009) 2.51
Alpha1-adrenoceptor subtypes and lower urinary tract symptoms. Int J Urol (2008) 1.55
Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure. J Mol Cell Cardiol (2010) 1.23
{alpha}1-Adrenergic receptor subtypes in nonfailing and failing human myocardium. Circ Heart Fail (2009) 1.13
Benign prostatic hyperplasia: from bench to clinic. Korean J Urol (2012) 0.96
Naftopidil for the treatment of urinary symptoms in patients with benign prostatic hyperplasia. Ther Clin Risk Manag (2011) 0.96
Comparing efficacy of α1D-receptor antagonist naftopidil and α1A/D-receptor antagonist tamsulosin in management of distal ureteral stones. World J Urol (2011) 0.96
Overactive bladder in males. Ther Adv Urol (2009) 0.88
Management of benign prostatic hyperplasia with silodosin. Open Access J Urol (2009) 0.87
Clinical feature of men who benefit from dose escalation of naftopidil for lower urinary tract symptoms: a prospective study. Adv Urol (2011) 0.83
Clinical efficacy of a loading dose of naftopidil for patients with benign prostate hyperplasia. World J Urol (2010) 0.83
Current evaluation and treatment of nocturia. Korean J Urol (2013) 0.83
Naftopidil and tolterodine in the medical expulsive therapy for intramural ureteral stones: a prospective randomized study. Urol Res (2012) 0.83
Subtypes of alpha1-adrenoceptors in BPH: future prospects for personalized medicine. Nat Clin Pract Urol (2009) 0.82
Benign prostatic hyperplasia and male lower urinary tract symptoms (LUTS). BMJ Clin Evid (2011) 0.81
Involvement of magnitude of ambient temperature change in nonspecific effect in perceived placebo effect on lower urinary tract symptoms: study on switching of naftopidil in patients with benign prostatic hyperplasia. Res Rep Urol (2013) 0.81
α(1)-adrenoceptor blocker naftopidil improves sleep disturbance with reduction in nocturnal urine volume. World J Urol (2010) 0.80
Comparative evaluation of naftopidil and tamsulosin in the treatment of patients with lower urinary tract symptoms with benign prostatic hyperplasia. Urol Ann (2014) 0.80
Divergent label-free cell phenotypic pharmacology of ligands at the overexpressed β₂-adrenergic receptors. Sci Rep (2014) 0.80
Randomized controlled trial to compare the safety and efficacy of naftopidil and tamsulosin as medical expulsive therapy in combination with prednisolone for distal ureteral stones. Korean J Urol (2013) 0.79
Functional alpha-1B adrenergic receptors on human epicardial coronary artery endothelial cells. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.79
Does prostate volume affect the efficacy of α1D/A: Adrenoceptor antagonist naftopidil? Urol Ann (2016) 0.78
Search for new alpha1a-adrenoceptor-selective antagonist for treating lower urinary tract symptoms associated with benign prostatic hyperplasia. Indian J Urol (2007) 0.78
A comparison of the efficacy of naftopidil and tamsulosin hydrochloride in medical treatment of benign prostatic enlargement. Urol Ann (2015) 0.78
Investigation of ejaculatory disorder by silodosin in the treatment of prostatic hyperplasia. BMC Urol (2012) 0.77
Comparative evaluation of efficacy of use of naftopidil and/or celecoxib for medical treatment of distal ureteral stones. Urolithiasis (2014) 0.76
Pharmacological characterization of N1-(2-methoxyphenyl)-N4-hexylpiperazine as a multi-target antagonist of α1A/α1D-adrenoceptors and 5-HT1A receptors that blocks prostate contraction and cell growth. Naunyn Schmiedebergs Arch Pharmacol (2013) 0.76
Nocturia: The circadian voiding disorder. Investig Clin Urol (2016) 0.75
A Randomized, Open-Label, Comparative Study of Efficacy and Safety of Tolterodine Combined with Tamsulosin or Doxazosin in Patients with Benign Prostatic Hyperplasia. Med Sci Monit (2016) 0.75
Clinical Efficacy and Safety of Naftopidil Treatment for Patients with Benign Prostatic Hyperplasia and Hypertension: A Prospective, Open-Label Study. Yonsei Med J (2017) 0.75
Effects of Combination Treatment of Alpha 1-Adrenergic Receptor Antagonists on Voiding Dysfunction: Study on Target Organs in Overactive Bladder Rats. Int Neurourol J (2016) 0.75
The prostatic urethral angle can predict the response to alpha adrenoceptor antagonist monotherapy for treating nocturia in men with lower urinary tract symptom: A multicenter study. Prostate Int (2016) 0.75
New Attempts to Overcome the Urinary Tract Disorders. Int Neurourol J (2016) 0.75
The predictive factors of α1-D/A adrenoceptor antagonist, naftopidil, dose increase therapy for male lower urinary tract symptoms caused by benign prostatic hyperplasia: INFORM study. Urol Ann (2017) 0.75
Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in Central Japan. Antimicrob Agents Chemother (2005) 2.81
Prevalence of genital mycoplasmas and ureaplasmas in men younger than 40 years-of-age with acute epididymitis. Int J Urol (2011) 2.08
Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Biochem Biophys Res Commun (2008) 2.08
Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval. J Infect Chemother (2003) 2.00
Threat to cefixime treatment for gonorrhea. Emerg Infect Dis (2007) 1.90
Quantitative detection of Mycoplasma genitalium from first-pass urine of men with urethritis and asymptomatic men by real-time PCR. J Clin Microbiol (2002) 1.78
Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones. Antimicrob Agents Chemother (2004) 1.73
MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression. J Biol Chem (2010) 1.66
The role of Mycoplasma genitalium and Ureaplasma urealyticum biovar 2 in postgonococcal urethritis. Clin Infect Dis (2007) 1.64
Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells. Int J Urol (2011) 1.56
A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells. Biochem Biophys Res Commun (2008) 1.52
Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemia. Am J Hum Genet (2013) 1.52
Crystal structures of the reaction intermediate and its homologue of an extradiol-cleaving catecholic dioxygenase. J Mol Biol (2002) 1.50
MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms. Prostate (2010) 1.44
Mutations in UVSSA cause UV-sensitive syndrome and impair RNA polymerase IIo processing in transcription-coupled nucleotide-excision repair. Nat Genet (2012) 1.38
Nationwide survey of urogenital tuberculosis in Japan. Int J Urol (2014) 1.38
Phylogeny-based rapid identification of mycoplasmas and ureaplasmas from urethritis patients. J Clin Microbiol (2002) 1.15
Rapid detection of the mosaic structure of the Neisseria gonorrhoeae penA Gene, which is associated with decreased susceptibilities to oral cephalosporins. J Clin Microbiol (2008) 1.15
Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance. Int J Antimicrob Agents (2010) 1.09
Abscess of the corpus cavernosum. Int J Infect Dis (2007) 1.09
Effect of edema on postimplant dosimetry in prostate brachytherapy using CT/MRI fusion. Int J Radiat Oncol Biol Phys (2007) 1.03
Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma. Urology (2007) 1.02
Rapid detection of Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum, and Ureaplasma urealyticum organisms in genitourinary samples by PCR-microtiter plate hybridization assay. J Clin Microbiol (2003) 1.00
Rapid detection of quinolone resistance-associated gyrA mutations in Neisseria gonorrhoeae with a LightCycler. J Infect Chemother (2002) 1.00
Quantitative detection of Ureaplasma parvum (biovar 1) and Ureaplasma urealyticum (biovar 2) in urine specimens from men with and without urethritis by real-time polymerase chain reaction. Sex Transm Dis (2007) 0.98
Decreased affinity of mosaic-structure recombinant penicillin-binding protein 2 for oral cephalosporins in Neisseria gonorrhoeae. J Antimicrob Chemother (2007) 0.98
New Clinical Strain of Neisseria gonorrhoeae with Decreased Susceptibility to Ceftriaxone, Japan. Emerg Infect Dis (2016) 0.97
Selection of Mycoplasma genitalium strains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 g dose of azithromycin. Sex Transm Infect (2011) 0.97
Nutritional screening with Subjective Global Assessment predicts hospital stay in patients with digestive diseases. Nutrition (2007) 0.96
[Solitary fibrous tumor of the urinary bladder: a case report]. Hinyokika Kiyo (2012) 0.95
Bilateral primary malignant lymphoma of the ureter. Int J Clin Oncol (2007) 0.95
Comparison of MRI-based and CT/MRI fusion-based postimplant dosimetric analysis of prostate brachytherapy. Int J Radiat Oncol Biol Phys (2006) 0.95
Cultivation of Neisseria gonorrhoeae in liquid media and determination of its in vitro susceptibilities to quinolones. J Clin Microbiol (2005) 0.94
Cisplatin induces production of reactive oxygen species via NADPH oxidase activation in human prostate cancer cells. Free Radic Res (2011) 0.94
Combined transplantation of pancreatic islets and adipose tissue-derived stem cells enhances the survival and insulin function of islet grafts in diabetic mice. Transplantation (2010) 0.93
A new prognostic classification for overall survival in Asian patients with previously untreated metastatic renal cell carcinoma. Cancer Sci (2012) 0.93
Photoaging and DNA repair. J Dermatol Sci (2007) 0.92
Olanzapine increases plasma ghrelin level in patients with schizophrenia. Psychoneuroendocrinology (2005) 0.92
CCR1/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2/9 and by activating ERK and Rac signaling. Cytokine (2013) 0.91
Hyaluronan synthase 3 regulates hyaluronan synthesis in cultured human keratinocytes. J Invest Dermatol (2002) 0.91
Efficacy of 1-day prophylaxis medication with fluoroquinolone for prostate biopsy. World J Urol (2005) 0.91
Macrolide resistance-associated 23S rRNA mutation in Mycoplasma genitalium, Japan. Emerg Infect Dis (2011) 0.91
Polymerase chain reaction-based subtyping of ureaplasma parvum and ureaplasma urealyticum in first-pass urine samples from men with or without urethritis. Sex Transm Dis (2005) 0.90
Lack of nationwide surveillance of antimicrobial resistance of Neisseria gonorrhoeae in Japan. Ann Intern Med (2008) 0.90
Nationwide surveillance of bacterial pathogens from patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2009 and 2010: antimicrobial susceptibility of Escherichia coli and Staphylococcus saprophyticus. J Infect Chemother (2013) 0.90
[Local recurrence of liposarcoma of the spermatic cord 6 years after orchiectomy: a case report]. Hinyokika Kiyo (2002) 0.89
[Recurrent spontaneous bladder rupture cured by conservative therapy: a case report]. Hinyokika Kiyo (2002) 0.88
Migration of prostate brachytherapy seeds to the vertebral venous plexus. Brachytherapy (2006) 0.87
Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma. Oncol Rep (2008) 0.87
[Two cases of prostatic stromal tumor of uncertain malignant potential (STUMP) on pathological diagnosis after surgery for benign prostatic hyperplasia]. Hinyokika Kiyo (2012) 0.87
A kavalactone derivative inhibits lipopolysaccharide-stimulated iNOS induction and NO production through activation of Nrf2 signaling in BV2 microglial cells. Pharmacol Res (2013) 0.87
The nationwide study of bacterial pathogens associated with urinary tract infections conducted by the Japanese Society of Chemotherapy. J Infect Chemother (2010) 0.87
Phosphorylation by extracellular signal-regulated kinase of a multidomain adaptor protein, vinexin, at synapses. J Neurochem (2007) 0.87
Management of pharyngeal gonorrhea is crucial to prevent the emergence and spread of antibiotic-resistant Neisseria gonorrhoeae. Antimicrob Agents Chemother (2012) 0.86
Treatment of men with urethritis negative for Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum. Int J Urol (2007) 0.85
Mycoplasma genitalium urethritis in men. Int J Antimicrob Agents (2004) 0.85
Contribution of topoisomerase IV mutation to quinolone resistance in Mycoplasma genitalium. Antimicrob Agents Chemother (2013) 0.85
Nocturia in men less than 50 years of age may be associated with obstructive sleep apnea syndrome. Urology (2008) 0.84
Acute renal failure due to bilateral ureteral stone impaction in an HIV-positive patient. Urol Res (2008) 0.84
[Clinical usefulness of chlormadinone acetate as an alternative antiandrogen therapy for prostate cancer relapse after combined androgen blockade therapy]. Hinyokika Kiyo (2009) 0.84
Drug resistance-associated mutations in Mycoplasma genitalium in female sex workers, Japan. Emerg Infect Dis (2015) 0.84
Chemopreventive effects of a flavonoid antioxidant silymarin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice. Jpn J Cancer Res (2002) 0.84
Lifestyle and health factors associated with stress urinary incontinence in Japanese women. Maturitas (2010) 0.84
Rhododendrol, a depigmentation-inducing phenolic compound, exerts melanocyte cytotoxicity via a tyrosinase-dependent mechanism. Pigment Cell Melanoma Res (2014) 0.84
MRI-based preplanning in low-dose-rate prostate brachytherapy. Radiother Oncol (2007) 0.84
gyrB and parE mutations in urinary Mycoplasma genitalium DNA from men with non-gonococcal urethritis. Int J Antimicrob Agents (2010) 0.84
[A case of prostate cancer with cyst formation]. Hinyokika Kiyo (2003) 0.84
Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: radiological findings mimicking papillary subtype. J Magn Reson Imaging (2011) 0.83
Possible interaction of a Rho effector, Rhotekin, with a PDZ-protein, PIST, at synapses of hippocampal neurons. Neurosci Res (2006) 0.83
Proteinase 3 anti-neutrophil cytoplasmic antibody (PR3-ANCA) positive IgG4-related retroperitoneal fibrosis: utility of PET-CT with 18F-fluorodeoxy glucose (FDG). Intern Med (2012) 0.82
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution]. Jpn J Antibiot (2006) 0.82
[Ethylene glycol poisoning complicated by central nervous system abnormalities]. Chudoku Kenkyu (2004) 0.82
Bacillus okuhidensis sp. nov., isolated from the Okuhida spa area of Japan. Int J Syst Evol Microbiol (2002) 0.82
Evaluation of quality of life in patients with previously untreated advanced prostate cancer receiving maximum androgen blockade therapy or LHRHa monotherapy: a multicenter, randomized, double-blind, comparative study. J Cancer Res Clin Oncol (2008) 0.81
The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer. Int J Urol (2008) 0.81
Identification of organoselenium compounds that possess chemopreventive properties in human prostate cancer LNCaP cells. Bioorg Med Chem (2010) 0.81
Nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan. J Infect Chemother (2013) 0.80
A multicenter retrospective survey of poisoning after consumption of products containing synthetic chemicals in Japan. Intern Med (2014) 0.80
[Bilateral renal cell carcinoma associated with polycystic kidney disease: case report and literature review]. Hinyokika Kiyo (2007) 0.80
Clinical and microbiological outcomes in treatment of men with non-gonococcal urethritis with a 100-mg twice-daily dose regimen of sitafloxacin. J Infect Chemother (2012) 0.80
Significance of an E-cadherin gene promoter polymorphism for risk and disease severity of prostate cancer in a Japanese population. Urology (2007) 0.80
Utility of Bcl-2, P53, Ki-67, and caveolin-1 immunostaining in the prediction of biochemical failure after radical prostatectomy in a Japanese population. Urology (2008) 0.80
A pretreatment nomogram predicting recurrence- and progression-free survival for nonmuscle invasive bladder cancer in Japanese patients. Int J Clin Oncol (2010) 0.80